Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$207.01 - $276.09 $20,493 - $27,332
-99 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$255.65 - $303.1 $12,271 - $14,548
48 Added 94.12%
99 $27,000
Q4 2019

Feb 14, 2020

BUY
$166.71 - $223.91 $8,502 - $11,419
51 New
51 $11,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Mirova Portfolio

Follow Mirova and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirova, based on Form 13F filings with the SEC.

News

Stay updated on Mirova with notifications on news.